MDV Form 4: Director Kimberly Smith Buys 1,024 Shares at $14.64
Kimberly J. Smith, a director of Modiv Industrial, Inc. (MDV), reported purchasing 1,024.5902 shares of Class C common stock on 09/30/2025 at $14.64 per share.
Rhea-AI Filing Summary
Kimberly J. Smith, a director of Modiv Industrial, Inc. (MDV), reported purchasing 1,024.5902 shares of Class C common stock on 09/30/2025 at $14.64 per share. After the transaction she beneficially owned 15,700.0068 shares. The Form 4 was signed by John Raney by power of attorney on 10/01/2025.
Positive
- Director purchase disclosed: Kimberly J. Smith acquired 1,024.5902 Class C shares, aligning insider interests with shareholders
Negative
- None.
Insights
TL;DR: A director made a modest open-market purchase; transaction size appears routine and not material to valuation.
The Form 4 discloses a 9/30/2025 acquisition of 1,024.5902 Class C shares at $14.64, increasing the director's beneficial holding to 15,700.0068 shares. The filing shows standard disclosure and a signature by power of attorney on 10/01/2025. Given the absolute size relative to typical institutional holdings, this is likely an individual-level transaction without clear material impact on company fundamentals.
TL;DR: Routine insider purchase by a director; disclosure complies with Section 16 reporting requirements.
The report identifies Kimberly J. Smith as a director who acquired shares and properly filed a Form 4. The signature by an agent under power of attorney is noted, which is acceptable practice when authorized. There are no derivative transactions or other governance concerns disclosed in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | COMMON STOCK, CLASS C | 1,024.5902 | $14.64 | $15K |
FAQ
What did MDV director Kimberly J. Smith report on Form 4?
When was the Form 4 signed and by whom?
Was the reported transaction in MDV stock a purchase or a sale?
Does the filing show any derivative securities transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.